MIRA INFORM REPORT

 

 

Report Date :

26.04.2012

 

IDENTIFICATION DETAILS

 

Name :

AL DEBEIKY FOR PHARMACEUTICAL INDUSTRIES

 

 

Registered Office :

23rd Sakr Koriesk Building, Sheraton Area, Heliopolis, Nasr City, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2011

 

 

Year of Establishment :

1998

 

 

Com. Reg. No.:

7554, Cairo

 

 

Legal Form :

Limited Liability Partnership

 

 

Line of Business :

Manufacture of pharmaceuticals for human and veterinary use

 

 

No. of Employees :

240

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Egypt

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SUMMARY

 

Company Name                         : AL DEBEIKY FOR PHARMACEUTICAL INDUSTRIES

Also Known As                                      : AL DEBEIKY PHARMA

Country of Origin                                    : Egypt

Legal Form                                            : Limited Liability Partnership

Start Date                                             : 1998

Registration Date                                   : 5th September 2001

Commercial Registration Number            : 7554, Cairo

Tax Card Number                                   : 210-140-348

Issued Capital                                        : £E 150,000,000

Paid up Capital                                      : £E 150,000,000

Total Workforce                         : 240

Activities                                               : Manufacture of pharmaceuticals for human and veterinary use.

Financial Condition                                 : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                         : Steady

Person Interviewed                                 : Inaas Hamdy, Administrative Secretary

 

 

 

COMPANY NAME

 

AL DEBEIKY FOR PHARMACEUTICAL INDUSTRIES

 

 

ALSO KNOWN AS

 

AL DEBEIKY PHARMA

 

 

company ADDRESS

 

Registered & Physical Address

Building : 23rd Sakr Koriesk Building

Street               : Sheraton Area

Area                 : Heliopolis, Nasr City

Town                 : Cairo

Country : Egypt

Telephone         : (20-2) 22661393 / 22684840 / 22681119

Facsimile          : (20-2) 22661370

Email                : sales@dbk-eg.com

 

Premises

Subject operates from a large suite of offices that are rented and located in the Central Business Area of Cairo

 

Branch Office (s)

 

     Location                                                                                          Description

 

·       Zone 11, Block 12014, Industrial Zone                                     Factory premises

El Obour City

Cairo

Tel: (20-2) 46651407

Fax: (20-2) 46651409

 

·       58 Joseph Tito Street                                                             Office premises

El Nozha El Gedida

Cairo

Tel: (20-2) 26220884

Fax: (20-2) 26246619

 

 

KEY PRINCIPALS

 

     Name                                                                                              Position

 

·       Dr Hamdy Ahmed Mohamed Zeyad El Debeiky                                    Managing Partner

 

·       Dr Sana Hamdy Ahmed Mohamed Zeyad El Debeiky                           Partner

 

·       Duwaa Hamdy Ahmed Mohamed Zeyad El Debeiky                             Partner

 

·       Noha Hamdy Ahmed Mohamed Zeyad El Debeiky                                Partner

 

·       Ayaa Hamdy Ahmed Mohamed Zeyad El Debeiky                                Partner

 

·       Mirvat Lotfy                                                                                       Partner

 

·       Said Keskhah                                                                                   General Manager

 

·       Dr Wael El Said                                                                                Medical Manager

 

·       Dr Tarek Ibrahim                                                                                Administration Manager

 

·       Dr Ihab Tawfiq                                                                                   Commercial Manager

 

·       Dr Alaa Ajlaan                                                                                   Scientific Manager

 

·       Inaas Hamdy                                                                                    Administrative Secretary

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : Subject’s operations date back to 1998, however it was registered on 5th September 2001.

 

Legal Form                  : Limited Liability Partnership

 

Commercial Reg. No.  : 7554, Cairo

 

Tax Card No.               : 210-140-348

 

Issued Capital              : £E 150,000,000

 

Paid up Capital            : £E 150,000,000

 

Name of Shareholder (s)

·       Dr Hamdy Ahmed Mohamed Zeyad El Debeiky

·       Dr Sana Hamdy Ahmed Mohamed Zeyad El Debeiky

·       Duwaa Hamdy Ahmed Mohamed Zeyad El Debeiky

·       Noha Hamdy Ahmed Mohamed Zeyad El Debeiky

·       Ayaa Hamdy Ahmed Mohamed Zeyad El Debeiky

·       Mirvat Lotfy

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of pharmaceuticals for human and veterinary use.

 

Import Countries: India and Europe

 

Operating Trend: Steady

 

Subject has a workforce of approximately 240 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)

 

                                                Year Ending 31/12/10:                Year Ending 31/12/11:

 

Total Sales                                £E 142,000,000                         £E 145,500,000

 

Local sources consider subject’s financial condition to be Fair.

 

The above financial figures are based on estimations by our local sources.

 

BANKERS

 

·       Export Development Bank of Egypt

108 Mohi El Din Abu El Ezz Street

     Mohandessin

     Cairo 11111

     Tel: (20-2) 33619005 / 33385877

     Fax: (20-2) 33385940 / 33385938

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.52.49

UK Pound

1

Rs.84.66

Euro

1

Rs.69.25

 

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.